BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 3524932)

  • 1. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
    Byrnes JJ; Moake JL
    Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Moake JL; McPherson PD
    Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura.
    Moake JL; Byrnes JJ; Troll JH; Rudy CK; Hong SL; Weinstein MJ; Colannino NM
    Blood; 1985 May; 65(5):1232-6. PubMed ID: 3873262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombotic microangiopathies: HUS/TTP. Physiopathological aspects].
    Sánchez Avalos JC
    Medicina (B Aires); 2000; 60(1):46-58. PubMed ID: 10835700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic thrombocytopenic purpura and related disorders.
    Ruggenenti P; Remuzzi G
    Hematol Oncol Clin North Am; 1990 Feb; 4(1):219-41. PubMed ID: 2107174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS).
    Kakishita E
    Int J Hematol; 2000 Jun; 71(4):320-7. PubMed ID: 10905050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review.
    Bosch T; Wendler T
    Ther Apher; 2001 Jun; 5(3):182-5. PubMed ID: 11467754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic thrombocytopenic purpura--a syndrome caused by multiple pathogenetic mechanisms.
    Lian EC
    Invest Clin; 2001 May; 42 Suppl 1():75-86. PubMed ID: 11416985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
    Moake JL
    Arch Pathol Lab Med; 2002 Nov; 126(11):1430-3. PubMed ID: 12421153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrecognized pattern of von Willebrand factor abnormalities in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.
    Galbusera M; Benigni A; Paris S; Ruggenenti P; Zoja C; Rossi C; Remuzzi G
    J Am Soc Nephrol; 1999 Jun; 10(6):1234-41. PubMed ID: 10361861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic thrombocytopenic purpura: understanding a disease no longer rare.
    Moake JL; Chow TW
    Am J Med Sci; 1998 Aug; 316(2):105-19. PubMed ID: 9704664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
    Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
    Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic thrombocytopenic purpura.
    Moake JL
    Thromb Haemost; 1995 Jul; 74(1):240-5. PubMed ID: 8578465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
    Moake JL
    Annu Rev Med; 2002; 53():75-88. PubMed ID: 11818464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced platelet adhesion and aggregation by endothelial cell-derived unusually large multimers of von Willebrand factor.
    Kumar RA; Moake JL; Nolasco L; Bergeron AL; Sun C; Dong JF; McIntire LV
    Biorheology; 2006; 43(5):681-91. PubMed ID: 17047284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of von Willebrand factor (vWF) in thrombotic thrombocytopenic purpura (TTP) and the hemolytic-uremic syndrome (HUS).
    Moake JL
    Prog Clin Biol Res; 1990; 337():135-40. PubMed ID: 2191307
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay.
    Casonato A; Fabris F; Pontara E; Cattini MG; Zocca N; Gallinaro L; Girolami A; Pagnan A
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):296-304. PubMed ID: 16959682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.